Company Filing History:
Years Active: 2016
Title: Pascale Ythier-Moury: Innovator in Cardiac Treatment
Introduction
Pascale Ythier-Moury is a notable inventor based in Paris, France. He has made significant contributions to the field of medicine, particularly in the treatment of myocardial infarction in elderly and renal-impaired patients. His innovative approach has led to the development of a unique pharmaceutical solution.
Latest Patents
Pascale Ythier-Moury holds a patent for the invention titled "Otamixaban for treatment of elderly and renal impaired non-ST elevation myocardial infarction patients." This invention relates to the use of (2R,3R)-2-(3-carbamimidoyl-benzyl)-3-[4-(1-oxy-pyridin-4-yl)benzoylamino]-butyric acid methyl ester or a pharmaceutically acceptable salt thereof. The patent outlines the preparation of a medicament for use in non-ST elevation myocardial infarction, specifically targeting human patients who are elderly, show renal insufficiency, or have a low body weight.
Career Highlights
Pascale Ythier-Moury is associated with Sanofi, a leading global healthcare company. His work at Sanofi has been instrumental in advancing medical treatments that cater to vulnerable patient populations. His dedication to innovation in the pharmaceutical field is evident through his research and development efforts.
Collaborations
Pascale has collaborated with notable colleagues, including Jens Stechl and Angele Moryusef. These partnerships have fostered a collaborative environment that enhances the development of effective medical solutions.
Conclusion
Pascale Ythier-Moury exemplifies the spirit of innovation in the medical field. His contributions, particularly through his patent for Otamixaban, highlight the importance of targeted treatments for specific patient demographics. His work continues to impact the healthcare industry positively.